We are live on ! Find out more

134 hedge funds and large institutions have $291M invested in Axogen in 2021 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 50 increasing their positions, 35 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

896% more call options, than puts

Call options by funds: $1.61M | Put options by funds: $162K

56% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 18

43% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 35

8% more funds holding

Funds holding: 124134 (+10)

0.81% less ownership

Funds ownership: 75.62%74.8% (-0.81%)

41% less capital invested

Capital invested by funds: $495M → $291M (-$204M)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
134
Holders Change
+10
Holders Change %
+8.06%
% of All Funds
2.06%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
28
Increased
50
Reduced
35
Closed
18
Calls
$1.61M
Puts
$162K
Net Calls
+$1.45M
Net Calls Change
+$1.5M
Name Holding Trade Value Shares
Change
Change in
Stake
TAM
26
Tocqueville Asset Management
New York
$2.72M +$2.1M +175,000 +152%
PCM
27
Perkins Capital Management
Minnesota
$2.6M +$47.4K +3,950 +1%
FA
28
Friess Associates
Delaware
$2.43M -$102K -8,498 -3%
KCM
29
Kennedy Capital Management
Missouri
$2.41M -$313K -26,093 -9%
Baillie Gifford & Co
30
Baillie Gifford & Co
United Kingdom
$2.36M -$10.9M -910,224 -78%
Jacobs Levy Equity Management
31
Jacobs Levy Equity Management
New Jersey
$1.96M +$2.38M +198,802 +1,966%
PHP
32
Parkman Healthcare Partners
Connecticut
$1.94M +$79.1K +6,598 +3%
Marshall Wace
33
Marshall Wace
United Kingdom
$1.78M +$2.28M +189,942 New
AGA
34
Altrinsic Global Advisors
Connecticut
$1.69M +$600K +50,000 +38%
Ameriprise
35
Ameriprise
Minnesota
$1.57M +$2.01M +167,833 New
RHJA
36
Rice Hall James & Associates
California
$1.5M -$57.9K -4,827 -3%
N
37
Nuveen
North Carolina
$1.44M -$91.3K -7,613 -5%
Two Sigma Investments
38
Two Sigma Investments
New York
$1.14M +$1.45M +121,178 New
Bank of New York Mellon
39
Bank of New York Mellon
New York
$1.13M +$31.3K +2,609 +2%
GF
40
Gabelli Funds
New York
$1.03M +$484K +40,311 +58%
Wells Fargo
41
Wells Fargo
California
$855K -$305K -25,400 -22%
Swiss National Bank
42
Swiss National Bank
Switzerland
$797K
Skandinaviska Enskilda Banken (SEB)
43
Skandinaviska Enskilda Banken (SEB)
Sweden
$759K
EGM
44
Engineers Gate Manager
New York
$741K +$529K +44,113 +126%
GPCM
45
Granite Point Capital Management
Massachusetts
$740K -$612K -50,990 -39%
PPA
46
Parametric Portfolio Associates
Washington
$687K +$1.14K +95 +0.1%
Goldman Sachs
47
Goldman Sachs
New York
$567K +$518K +43,144 +248%
Barclays
48
Barclays
United Kingdom
$519K +$340K +28,310 +105%
California State Teachers Retirement System (CalSTRS)
49
California State Teachers Retirement System (CalSTRS)
California
$507K +$20.6K +1,716 +3%
Two Sigma Advisers
50
Two Sigma Advisers
New York
$440K +$197K +16,400 +54%

AXGN Hedge Fund Activity: Q4 2021 in Review

134 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Axogen (AXGN) for Q4 2021, worth a combined $291M — down 41% from $495M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new AXGN positions and 18 closed out — a net gain of 10 holders — while 50 added to existing stakes and 35 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $6.49M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $17.8M sold.

  • 134 institutional investors held Axogen (AXGN) as of Q4 2021, up from 124 in Q3 2021.
  • Funds reported $291M of Axogen stock for Q4 2021, down 41% quarter-over-quarter.
  • 28 funds opened new Axogen positions in Q4 2021 and 18 closed out, a net change of +10 holders.
  • The largest Axogen buyer in Q4 2021 was Morgan Stanley, an estimated $6.49M added.
  • The largest Axogen seller in Q4 2021 was Point72 Asset Management, an estimated $17.8M sold.

Based on aggregated 13F filings for Q4 2021.